Glucagon-like Peptide-1 Agonists Cut Events Beyond Diabetes 04/03/26
Welcome to Cardiology Today â Recorded April 03, 2026. This episode summarizes 5 key cardiology studies on topics like incident hypertension and quadruple guideline-directed medical therapies. Key takeaway: Glucagon-like Peptide-1 Agonists Cut Events Beyond Diabetes.
Article Links:
Article 1: Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. (European heart journal)
Article 2: Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 3: Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. (JAMA cardiology)
Article 4: Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum. (JAMA cardiology)
Article 5: Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During LVAD Support. (ESC heart failure)
Full episode page: https://podcast.explainheart.com/podcast/glucagon-like-peptide-1-agonists-cut-events-beyond-diabetes-04-03-26/
đ Featured Articles
Article 1: Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926331
Summary: Glucagon-like peptide-1 receptor agonists (G. L. P. minus 1 R. A.s) significantly reduced atherosclerosis burden and inflammatory biomarkers in experimental rabbit models. In clinical subjects, these agents decreased inflammatory biomarkers and major adverse cardiovascular events (MACE). These beneficial cardiovascular effects were observed irrespective of the patients’ glycemic status or obesity, indicating a direct cardiovascular protective mechanism.
Article 2: Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40701206
Summary: A ten-minute asystolic warm ischemic time (A. W. I. T.) during donation after circulatory death (D. C. D.) heart recovery significantly predicted increased mortality in adult heart transplant recipients. This prolonged warm ischemic time was also associated with severe primary graft dysfunction. These findings specifically apply to cardiac allografts recovered using thoracoabdominal normothermic regional perfusion (N. R. P.).
Article 3: Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920552
Summary: The study characterized the time to quadruple guideline-directed medical therapies (G. D. M. T.s) following an initial diagnosis of heart failure with reduced ejection fraction (H. F. rEF). It identified specific factors associated with achieving timely initiation of these therapies in a large cohort of patients. The findings provide contemporary estimates on the duration and facilitators of initiating optimal quadruple therapy for patients with H. F. rEF.
Article 4: Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum.
Journal: JAMA cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41920533
Summary: The study found that genetic risk for high systolic blood pressure (S. B. P.) significantly stratified the risk of new-onset hypertension in women. This association was observed at two to seven years post partum. The genetic risk was an independent predictor, separate from women’s clinical characteristics and history of hypertensive disorders of pregnancy (H. D. P.), including preeclampsia, eclampsia, and gestational hypertension.
Article 5: Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During LVAD Support.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926705
Summary: V. A. D. Support. Observational studies revealed an association between phosphodiesterase-5 inhibitors, specifically sildenafil, and lower mortality and ischemic stroke in patients undergoing durable left ventricular assist device (L. V. A. D.) support. This study conducted a double-blind, randomized, placebo-controlled investigation into sildenafil’s causal effects on platelet activation and circulating mediators of vascular remodeling. This research aims to understand the direct physiological impact of sildenafil that could explain its previously observed clinical benefits in this patient population.
đ Transcript
Today’s date is April 03, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity. Glucagon-like peptide-1 receptor agonists (G. L. P. minus 1 R. A.s) significantly reduced atherosclerosis burden and inflammatory biomarkers in experimental rabbit models. In clinical subjects, these agents decreased inflammatory biomarkers and major adverse cardiovascular events (MACE). These beneficial cardiovascular effects were observed irrespective of the patients’ glycemic status or obesity, indicating a direct cardiovascular protective mechanism.
Article number two. Ten-minute asystolic warm ischemic time (AWIT) predicts mortality and severe primary graft dysfunction in donation after circulatory death hearts recovered with thoracoabdominal normothermic regional perfusion. A ten-minute asystolic warm ischemic time (A. W. I. T.) during donation after circulatory death (D. C. D.) heart recovery significantly predicted increased mortality in adult heart transplant recipients. This prolonged warm ischemic time was also associated with severe primary graft dysfunction. These findings specifically apply to cardiac allografts recovered using thoracoabdominal normothermic regional perfusion (N. R. P.).
Article number three. Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. The study characterized the time to quadruple guideline-directed medical therapies (G. D. M. T.s) following an initial diagnosis of heart failure with reduced ejection fraction (H. F. rEF). It identified specific factors associated with achieving timely initiation of these therapies in a large cohort of patients. The findings provide contemporary estimates on the duration and facilitators of initiating optimal quadruple therapy for patients with H. F. rEF.
Article number four. Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum. The study found that genetic risk for high systolic blood pressure (S. B. P.) significantly stratified the risk of new-onset hypertension in women. This association was observed at two to seven years post partum. The genetic risk was an independent predictor, separate from women’s clinical characteristics and history of hypertensive disorders of pregnancy (H. D. P.), including preeclampsia, eclampsia, and gestational hypertension.
Article number five. Effect of Sildenafil on Platelet Activation and Mediators of Vascular Remodeling During L. V. A. D. Support. Observational studies revealed an association between phosphodiesterase-5 inhibitors, specifically sildenafil, and lower mortality and ischemic stroke in patients undergoing durable left ventricular assist device (L. V. A. D.) support. This study conducted a double-blind, randomized, placebo-controlled investigation into sildenafil’s causal effects on platelet activation and circulating mediators of vascular remodeling. This research aims to understand the direct physiological impact of sildenafil that could explain its previously observed clinical benefits in this patient population.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
incident hypertension, quadruple guideline-directed medical therapies, glucagon-like peptide-1 receptor agonists, post partum, normothermic regional perfusion, hypertensive disorders of pregnancy, genetic risk, blood pressure, vascular remodeling, time to therapy, sildenafil, cardiovascular events, donation after circulatory death, atherosclerosis, primary graft dysfunction, platelet activation, Veterans Health Administration, left ventricular assist device, liraglutide, heart transplant, inflammatory biomarkers, heart failure with reduced ejection fraction, asystolic warm ischemic time, morbidity, phosphodiesterase-5 inhibitors.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow